fbpx

News & information

Level 1 study – EpiFix demonstrates Superior healing rates in DFUs vs SOC

EpiFix has demonstrated in previous studies very high rates of healing, with the original study showing 90%+ rates of healing in DFU wounds and 71% in VLU wounds.

With studies looking at long term follow up and the overall time to closure using weekly applications v biweekly, MiMedx demonstrates the effectiveness of EpiFix in hard to heal/non-healing ulcers.

The latest study further demonstrates this in a wider group of patients across multiple centres:

This further adds to the existing evidence for the use of Amniotic Tissue in wound healing and justification of advanced therapies in hard to heal and non healing wounds,

Evidence overview:

Multicentre RCT on DFU:

EP539.001 EpiFix Multicenter DFU Study Brochure

For more information on EpiFix please visit our EPIFIX Education page

Contact us

Share this:

Company

REGEN MEDICAL Ltd
Unit 11 Interface Business Park
Bincknoll Lane
Royal Wootton Bassett
Wiltshire
SN4 8SY

Part of the Joint Operations family

Company no. 11180724
VAT no. GB 329567956

Contact

OFFICE HOURS:

Mon - Fri 08:30 to 17:30
Tel. 01793 575 050

Email: 
customerservice@regenmedical.co.uk

OUT OF HOURS BURNS SUPPORT:

Tel. 01793 575 041

© Regen Medical
website development.: Clockwork Medical